48-kDa (Chen et al, 1994; Schultz-Thater et al, 1994; Kocker et al, 1995; Carrel et al, 1996; Gudat et al, 1996; Gunther et al, 1997) . Immunohistochemical studies in malignant melanomas have demonstrated that MAGE-1 gene product is a cytoplasmic protein clustered in paranuclear organelle-like structures (Schultz-Thater et al, 1994) . MAGE-3 protein also exists in cytoplasm showing homogeneous, focal or scattered pattern of expression, and the expression undergoes a substantial change in distribution with increase in tumour size and invasiveness (Gunther et al, 1997) .
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in East Asia, including Japan (Okuda, 1992) . Problems to be resolved clinically are how to discriminate welldifferentiated HCCs from non-cancerous lesions, and how to suppress the recurrences that frequently occur after treatment. In the present study, we have carried out the reverse transcription polymerase chain reaction (RT-PCR), the immunohistochemical and the Western blot analysis for MAGE-1 and -3 genes and gene products to determine whether detection of the genes, and whether the proteins is available for differential diagnosis of HCC, and whether the peptides derived from MAGE-1 and -3 proteins are suitable targets for the immunotherapy of human HCCs.
SUBJECTS AND METHODS
We examined 33 surgically resected HCCs. The specimens were cut into slices, formalin-fixed, paraffin-embedded and used for immunohistochemical analysis and for routine staining with haematoxylin and eosin. The samples were also immediately frozen after resection, and stored at -80°C until RNA and protein extraction. The erythroleukemia cell line K562 was used as a Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma K Kariyama positive control of MAGE-1 and -3 gene expression (Serrano et al, 1995) , while human testicular tissues were also used as a positive control for the immunostaining and the Western blot analysis (Carrel et al, 1996) .
A profile of the 33 patients enrolled in the present study is shown in Table 1 . The subjects were 25 males and eight females 42-75 years of age, and five cases were positive for HBs antigen, 27 were positive for hepatitis C virus (HCV) antibody and one was negative for both viral markers. Tumour-bearing non-cancerous tissues were chronic hepatitis in 16 patients and liver cirrhosis in 17 patients. As for tumour size, five were less than 20 mm, 26 were 20-50 mm and one was greater than 51 mm in diameter. The histological grade and clinical stage of HCC were classified according to the criteria outlined by the Liver Cancer Group of Japan (1989) . Well, moderately and poorly differentiated HCC comprised 12, 19 and two cases respectively, and stage I, II, III, IVA and IVB accounted for 9, 11, 8, 3 and 2 respectively. The positive rate of alpha-fetoprotein higher than 200 ng/ml was 33%. The study was approved by the institutional review board, and informed consent for the experimental use of specimens was obtained from all patients.
For the detection of MAGE genes, total RNA was extracted using RNAzolB reagent (Tel-Test Inc, Texas, USA) and 2 µg of RNA were used to synthesize cDNA by RAV-2 reverse transcriptase (Takara Biomedics, Osaka, Japan). The sequences of primers for PCR amplification were as follows: MAGE-1; sense, 5′-CGGCCGAAGGAACCTGACCCAG-3′ (CHO-14) and antisense, 5′-GCTGGAACCCTCACTGGGTTGCC-3′ (CHO-12), MAGE-3; sense, 5′-TGGAGGACCAGAGGCCCCC-3′ (AB-1197), antisense, 5′-GGACGATTATCAGGAGGCCTGC-3′ (BLE-5). We also performed RT-PCR for MAGE-4, -6 and -12 to confirm whether the monoclonal antibody against MAGE-3 protein used in the present study detected only MAGE-3 protein since this monoclonal antibody has recently been found to efficiently stain COS cells transfected with MAGE-4, -6 or -12 genes (T Boon, personal communication). The sequences of primers for PCR amplification were as follows: MAGE-4; sense, 5′-ACCAAGGAGAAGATCTGCCAGTGGGTCTC-3′ (MSFf-1) and antisense, 5′-GTCGCCCTCCATTGCATTGTGC-3′ (M41 Sr), MAGE-6; sense, 5′-TGGAGGACCAGAGGCCCCC-3′ (AB-1197), antisense, 5′-CAGGATGATTATCAGGAAGCCTGT-3′ (MAGE-6A). MAGE-12; sense, 5′-AGGTCAGAGAACAGC-GAGAT-3′
(MAGE-12S), antisense, 5′-TTCCTGTTCT-TCGTTGCTGG-3′ (MAGE-12A) (Lee et al, 1996) . The PCR reaction was carried out for 35 cycles: 1 min at 94°C and 4 min at 72°C followed by a final extension for 15 min at 72°C for MAGE-1, -3 and -6, and 1 min at 94°C and 1 min at 60°C and 3 min at 72°C followed by a final extension for 15 min for MAGE-4 and -12. The PCR products were electrophoresed on 1% agarose gel and visualized with ethidium bromide staining. The Western blot analysis was performed in 15 samples. Frozen HCC tissues were homogenized and insoluble cell debris was removed by centrifugation at 12 000 g for 30 min. Fifty micrograms protein were separated by 12.5% sodium dodecyl sulphate polyacrylamide gel electrophoresis under reducing conditions. The separated proteins were transferred to a nitrocellulose membrane and the membrane was blocked with 5% non-fat dry milk in phosphate-buffered saline (PBS) containing 0.1% Tween-20. Monoclonal antibodies against MAGE-1 (mAb 77B) or MAGE-3 (mAb 57B) were used in the present investigation. To generate these monoclonal antibodies BALB/c mice were immunized with 20 µg of the respective recombinant protein. Hybridoma supernatants were screened by ELISA for binding to the each protein used for immunization (Kocher et al, 1995; Carrel et al, 1996) . After overnight incubation with the respective undiluted mAb at 4°C, the membrane was washed with PBS/Tween-20, incubated with horseradish peroxidase (HRP)-conjugated goat anti-mouse second-step antibody (ECL Detection System, Amersham Japan, Tokyo, Japan) for 1 h. Chemiluminescence detection system was used to reveal specific binding (ECL Detection System, Amersham Japan, Tokyo, Japan), and protein bands were visualized on autoradiogrphy film. A commercially available marker of molecular weight (Sigma Chemical Company, Tokyo, Japan) was used.
The immunohistochemical analysis of MAGE-1 and -3 was carried out using the monoclonal antibodies mentioned above. Briefly, 4-µm-sliced sections were deparaffinized and heated in PBS for 10 min at 90°C. After blocking of the endogenous peroxidase activity and non-specific reactivity, the first reaction with the respective monoclonal antibodies was carried out for 1 h at room temperature. Biotin-conjugated anti-mouse immunoglobulin was used as the second antibody after which sections were treated with peroxidase-streptoavidin complex (Nichirei Co Ltd, Tokyo, Japan). The reactive products were visualized by staining with 30% 3,3′-diaminobenzidine tetrahydrochloride (Nichirei Co Ltd, Tokyo, Japan).
RESULTS

RT-PCR analysis for the MAGE-1 and -3 mRNAs
The expression of MAGE-1 and -3 genes in case 22 and the K562 cell were shown in Figure 1 . The expected products of 421 bp and 725 bp which corresponded to MAGE-1 and -3 gene respectively, were detected in HCC and K562 cells, but not in the noncancerous tissue (Figure 1 ).
Western blot analysis of the MAGE-1 and -3 gene products
The Western blot analysis for MAGE-1 and -3 gene products was performed in 15 HCC and two human testicular tissues. The molecular weight of MAGE-1 and -3 protein was 46-kDa and 48-kDa respectively, and both were clearly distinguishable. The respective gene products were positive exclusively in HCC and testicular tissues, and negative in the corresponding non-cancerous portions. A 72-kDa band, which was reported to be cross-reacted with anti MAGE-1 mAbs (Gudat et al, 1996) , was detected in two of 15 HCCs. A 31-kDa band was also observed in immunoblot analysis with mAb 57B. However, this band was only detected in testicular tissues (Figure 2 ).
Immunohistochemical studies of the MAGE-1 and -3 gene products
On immunohistochemistry, MAGE-1 protein was recognized in the cytoplasm of six HCC tissues: one showed homogenous and five a focal distribution, of which two exhibited nuclear staining. MAGE-3 protein was also detected in the cytoplasm of two HCC Expression of MAGE-1 and -3 gene products by western blot analysis using mAbs, 77B for MAGE-1 and 57B for MAGE-3. The molecular weight of MAGE-1 was 46-kDa and that of MAGE-3 protein was 48-kDa, respectively. These proteins were exclusively observed in HCC and the testicular tissue. A 72-kDa band which cross-reacted with the mAb 77B was also detected in two of 15 HCCs. A 31-kDa band was also detected with the mAb 57B only in the testicular tissue.
tissues. The staining pattern was homogenous or scattered in HCC nodules, and one was positive in the nucleus (Figures 3 and 4) .
mRNA and protein expression of MAGE-1 and -3 and clinicopathological features
The expression of MAGE-1 and -3 gene and gene product in all cases examined was shown in Table 2 . The positive rates in the expression of MAGE-1 and -3 gene were 21/27 (77.8%) and 11/26 (42.3%) respectively. Furthermore, their gene products examined by Western blot were positive in 12/15 (80.0%) and 9/15 (60.0%) respectively. However, in the immunohistochemical analysis MAGE-1 and -3 protein was detected only in 6/33 (18.2%) and 2/29 (6.9%) respectively, suggesting that the immunohistochemical analysis was less sensitive than the Western blotting. All of the samples positive in the immunohistochemical examination were positive in the corresponding gene detection analysis, although MAGE-1 and -3 genes were not detected in three samples positive in the Western blot analysis ( Table 2 ). The expression of MAGE-1 and -3 genes and proteins correlated with neither the histological grading nor the clinical staging of HCC (Table 3) .
Expression of MAGE-3, -4, -6 and -12 genes
Since there was a possibility that mAb 57B detected MAGE-4, -6 or -12 except for MAGE-3 protein, we analysed the correspondence between the respective gene and the protein expression. MAGE-4, -6 and -12 mRNA were expressed in 2/9 (22%), 7/9 (78%) and 0/9 (0%). The correspondent rates were 11/14 (79%), 2/9 (22%), 5/9 (56%) and 3/9 (33%) in MAGE-3, -4, -6 and -12 respectively, suggesting that mAb 57B reacted mainly with MAGE-3 gene product rather than the other proteins (Table 4) .
DISCUSSION
Several tumour-associated antigens, including MAGE, BAGE, GAGE families, Melan-A/MART-1, tyrosinase, gp100, have been identified using cytotoxic T-cell clones and T-cell lines isolated from melanoma patients (Bakker et al, 1995; Spagnoli et al, 1995; Marincola et al, 1996) . Among these tumour-associated antigens, MAGE-1 and -3 are two clinically relevant and their genes are expressed in a considerable proportion of melanomas and other malignancies. Our result concerning the expression of MAGE-1 gene in human HCCs agrees with that previously reported by Yamashita et al (1996) . For the induction of MAGE-1 and -3 antigen-specific tumour immunity in HCC patients, the peptide epitopes derived from these antigens should be expressed on the corresponding HLA class I molecules (Celis et al, 1994; van der Bruggen et al, 1994; Yamasaki et al, 1995) . Therefore, this study was designed to investigate whether MAGE-1 and -3 proteins are expressed in HCCs, and to determine whether the detection of the genes and proteins is a useful tool for differential diagnosis of HCCs from non-cancerous lesions. Our findings first provide new information with respect to the expression of MAGE-1 and -3 gene products in human HCCs. 
n.d., not done;*, positive for band at 72 kDa in Western blot analysis of MAGE-1. In the present study, we have demonstrated that MAGE-1 and -3 proteins were detected exclusively in HCC areas regardless of the histological grading and clinical staging. The positive rates of MAGE-1 and -3 proteins analyzed by the immunoblotting were higher than those examined by the immunohistochemical analysis. Gene and protein of MAGE-1 were more frequently expressed than those of MAGE-3 in human HCCs. Furthermore, we have recently attempted to detect the MAGE-1 gene in small samples gained by a 21-gauge thin-needle biopsy, and found the constitutive gene expression in early HCCs (solitary and less than 20 mm in diameter) ambiguous in histological examination. Thus, at the present time, the detection of MAGE-1 gene by RT-PCR or gene product by the Western blotting is the best choice for differential diagnosis of early HCCs from non-cancerous lesions.
Collective evidence indicates that MAGE-1 and -3 peptides are recognized by autologous cytotoxic T lymphocytes and can elicit cytolytic activity in a MHC class I-restricted manner in vitro or in vivo in the patients with melanoma or other malignancies (Celis et al, 1994; van der Bruggen et al, 1994; Yamasaki et al, 1995; Hu et al, 1996; Toso et al, 1996; Fleischhauer et al, 1997; Valomori et al, 1997) . A strong CTL response was induced in patients with advanced melanoma by vaccination of dendritic cells pulsed with a cocktail of peptides of tumour-associated antigens including MAGE-1 and -3 together with or without cell lysate (Nestlé et al, 1998) . The fact that not only the primary, but also metastatic, melanomas were regressed following vaccination suggests the clinical usefulness of the immunotherapy against tumour-associated antigen peptides. Many reports have indicated the possibility of vaccine therapy in malignant tumours with tumour-rejection antigen peptides; however, most of them did not show the protein expression in tumours. We clarified in the present study that the gene products of MAGE-1 and -3 were frequently expressed in HCCs and thus the possibility of immunotherapy against MAGE-1 or -3 epitopes in HCC patients could be envisaged moreover.
In conclusion, we demonstrated the expression of MAGE-1 and -3 genes and gene products in human HCCs. Our findings indicate that the detection of the genes and gene products of MAGE-1 and -3 is a useful tool for differential diagnosis between early HCCs and non-cancerous lesions, and immunotherapy targeting the peptides derived from MAGE-1 and -3 proteins appears to be feasible in patients with HCC.
